These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 18162225)
21. Oral health in cancer therapy. Rankin KV; Epstein J; Huber MA; Peterson DE; Plemons JM; Redding SS; Sanfillippo NJ; Schubert MM; Sonis ST Tex Dent J; 2009 May; 126(5):389-97, 406-19, 422-37. PubMed ID: 19492587 [No Abstract] [Full Text] [Related]
22. A myeloablative conditioning regimen for patients with impaired cardiac function undergoing allogeneic stem cell transplantation: reduced cyclophosphamide combined with etoposide and total body irradiation. Yoshimi A; Nannya Y; Sakata-Yanagimoto M; Oshima K; Takahashi T; Kanda Y; Motokura T; Chiba S; Kurokawa M Am J Hematol; 2008 Aug; 83(8):635-9. PubMed ID: 18506704 [TBL] [Abstract][Full Text] [Related]
27. Cardiac and pulmonary late effects do not negatively influence performance status and non-relapse mortality of children surviving five yr after autologous hematopoietic cell transplantation: report from the EBMT Paediatric Diseases and Late Effects Working Parties. Uderzo C; Pillon M; Tridello G; Dini G; Urban C; Corti P; Zintl F; Fagioli F; Messina C; Verdeguer A; Faraci M; Fedeli S; Tana F; Tichelli A; Passweg J; Rovelli A Pediatr Transplant; 2009 Sep; 13(6):719-24. PubMed ID: 18992061 [TBL] [Abstract][Full Text] [Related]
29. Similar risks for hypothyroidism after allogeneic hematopoietic cell transplantation using TBI-based myeloablative and reduced-intensity conditioning regimens. Al-Hazzouri A; Cao Q; Burns LJ; Weisdorf DJ; Majhail NS Bone Marrow Transplant; 2009 Jun; 43(12):949-51. PubMed ID: 19104492 [TBL] [Abstract][Full Text] [Related]
30. Artesunate as a potent antiviral agent in a patient with late drug-resistant cytomegalovirus infection after hematopoietic stem cell transplantation. Shapira MY; Resnick IB; Chou S; Neumann AU; Lurain NS; Stamminger T; Caplan O; Saleh N; Efferth T; Marschall M; Wolf DG Clin Infect Dis; 2008 May; 46(9):1455-7. PubMed ID: 18419454 [TBL] [Abstract][Full Text] [Related]
31. Gonadal shielding technique to preserve fertility in male pediatric patients treated with total body irradiation for stem cell transplantation. Sayan M; Cassidy RJ; Butker EE; Nanda RH; Krishnamurti L; Khan MK; Esiashvili N Bone Marrow Transplant; 2016 Jul; 51(7):997-8. PubMed ID: 26950374 [No Abstract] [Full Text] [Related]
33. Chronic kidney dysfunction in patients alive without relapse 2 years after allogeneic hematopoietic stem cell transplantation. Abboud I; Porcher R; Robin M; de Latour RP; Glotz D; Socié G; Peraldi MN Biol Blood Marrow Transplant; 2009 Oct; 15(10):1251-7. PubMed ID: 19747632 [TBL] [Abstract][Full Text] [Related]
34. Thrombotic complications after haematopoietic stem cell transplantation: early and late effects. Tsakiris DA; Tichelli A Best Pract Res Clin Haematol; 2009 Mar; 22(1):137-45. PubMed ID: 19285280 [TBL] [Abstract][Full Text] [Related]
35. Early and late neurological complications after reduced-intensity conditioning allogeneic stem cell transplantation. Barba P; Piñana JL; Valcárcel D; Querol L; Martino R; Sureda A; Briones J; Delgado J; Brunet S; Sierra J Biol Blood Marrow Transplant; 2009 Nov; 15(11):1439-46. PubMed ID: 19822304 [TBL] [Abstract][Full Text] [Related]
36. Low toxicity of a conditioning with 8-Gy total body irradiation, fludarabine and cyclophosphamide as preparative regimen for allogeneic hematopoietic stem cell transplantation in pediatric hematological malignancies. Yanagisawa R; Nakazawa Y; Sakashita K; Tanaka M; Shikama N; Kamijo T; Shiohara M; Koike K Pediatr Transplant; 2009 Sep; 13(6):737-45. PubMed ID: 19207225 [TBL] [Abstract][Full Text] [Related]
37. Impact of drug therapy, radiation dose, and dose rate on renal toxicity following bone marrow transplantation. Cheng JC; Schultheiss TE; Wong JY Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1436-43. PubMed ID: 18355974 [TBL] [Abstract][Full Text] [Related]
38. The impact of CD34+ cell dose on platelet engraftment in pediatric patients following unmanipulated haploidentical blood and marrow transplantation. Chang YJ; Xu LP; Liu DH; Liu KY; Han W; Chen YH; Wang Y; Chen H; Wang JZ; Zhang XH; Zhao XY; Huang XJ Pediatr Blood Cancer; 2009 Dec; 53(6):1100-6. PubMed ID: 19743519 [TBL] [Abstract][Full Text] [Related]
39. Evaluation of readmission in children receiving allogeneic hematopoietic stem cell transplantation: an institutional experience. Jaing TH; Tsay PK; Yang CP; Hung IJ; Wen YC; Tseng CK Transplant Proc; 2008 Dec; 40(10):3643-5. PubMed ID: 19100457 [TBL] [Abstract][Full Text] [Related]
40. Long-term follow-up of allogeneic hematopoietic stem cell transplantation for de novo acute myelogenous leukemia with a conditioning regimen of total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine. Mori T; Aisa Y; Watanabe R; Yamazaki R; Kato J; Shimizu T; Shigematsu N; Kubo A; Yajima T; Hibi T; Ikeda Y; Okamoto S Biol Blood Marrow Transplant; 2008 Jun; 14(6):651-7. PubMed ID: 18489990 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]